Literature DB >> 22215638

Management of subarachnoid hemorrhage with intracerebral hematoma: clipping and clot evacuation versus coil embolization followed by clot evacuation.

Kenneth de los Reyes1, Aman Patel, Joshua B Bederson, Jennifer A Frontera.   

Abstract

BACKGROUND: Aneurysmal subarachnoid hemorrhage (SAH) with associated intracerebral hemorrhage (ICH) is often treated with concomitant surgical clipping and ICH evacuation. The aim of this study was to determine if aneurysm coiling followed by ICH evacuation is a viable alternative treatment.
METHODS: A retrospective review was conducted between July 2000 and March 2009 of patients with aneurysmal SAH plus ICH (>30 ml or with midline shift >5 mm) who underwent aneurysm repair (either coiling or clipping) and craniotomy for ICH evacuation. Demographic and radiographic criteria, time to aneurysm protection, length of stay (LOS), treatment complications, discharge disposition and 3 month functional outcome were compared between groups.
RESULTS: Of 18 SAH+ICH patients, 10 underwent aneurysm coiling followed by ICH evacuation and eight underwent clipping with ICH evacuation. Compared with clipped patients, coiled patients had a lower Glasgow Coma Scale score (median 5.5 vs 7.5), higher ICH score (median 3 vs 2), worse modified Fisher score (median 4 vs 3) and higher rate of herniation at presentation (50% vs 25%). Median time to aneurysm protection was shorter in coiled patients (299 vs 885 min, p<0.001). Comparing coiled with clipped patients, rates of death (30% vs 25%), poor outcome (70% vs 50%), median ICU LOS (20 vs 22 days), median hospital LOS (27 vs 29 days) and total median direct costs ($64,537 vs $61,243) were similar, as were complication rates (all p>0.05).
CONCLUSIONS: Coiling followed by ICH evacuation is associated with faster time to aneurysm protection and similar outcome, LOS and cost as clipping and evacuation. This may be a viable alternative to clipping and ICH evacuation.

Entities:  

Mesh:

Year:  2012        PMID: 22215638     DOI: 10.1136/neurintsurg-2011-010204

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  6 in total

1.  Subarachnoid hemorrhage and intracerebral hematoma caused by aneurysms of the anterior circulation: influence of hematoma localization on outcome.

Authors:  Markus Bruder; Patrick Schuss; Joachim Berkefeld; Marlies Wagner; Hartmut Vatter; Volker Seifert; Erdem Güresir
Journal:  Neurosurg Rev       Date:  2014-07-12       Impact factor: 3.042

2.  Management of aneurysmal subarachnoid haemorrhage with intracerebral hematoma: Is there an indication for coiling first? Study of 44 cases.

Authors:  Céline Salaud; Olivier Hamel; Tanguy Riem; Hubert Desal; Kevin Buffenoir
Journal:  Interv Neuroradiol       Date:  2015-12-02       Impact factor: 1.610

3.  Decompressive Surgery in Patients with Poor-grade Aneurysmal Subarachnoid Hemorrhage: Clipping with Simultaneous Decompression Versus Coil Embolization Followed by Decompression.

Authors:  Ui Seung Hwang; Hee Sup Shin; Seung Hwan Lee; Jun Seok Koh
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2014-09-30

4.  Ruptured middle cerebral artery aneurysms with a concomitant intraparenchymal hematoma: the role of hematoma volume.

Authors:  I A Zijlstra; W E van der Steen; D Verbaan; C B Majoie; H A Marquering; B A Coert; W P Vandertop; R van den Berg
Journal:  Neuroradiology       Date:  2018-01-22       Impact factor: 2.804

5.  Endovascular Coiling Versus Neurosurgical Clipping for Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis.

Authors:  Syed Ijlal Ahmed; Gohar Javed; Syeda Beenish Bareeqa; Syeda Sana Samar; Ali Shah; Arwa Giani; Zainab Aziz; Abeer Tasleem; Syed Hasham Humayun
Journal:  Cureus       Date:  2019-03-26

6.  Keyhole Approach for Clipping Anterior Circulation Aneurysms: Clinical Outcomes and Technical Note.

Authors:  Dongqi Shao; Yu Li; Zhixiang Sun; Xintao Cai; Xialin Zheng; Zhiquan Jiang
Journal:  Front Surg       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.